Market View 1st June 2022

View on market: Stay Cautious, be with quality business:

Stocks in Asia rose on Wednesday, while U.S. futures advanced and bond yields gained amid concerns over aggressive monetary tightening. Shares were higher in Japan and Australia. S&P 500 and Nasdaq 100 futures gained. The Nasdaq 100 fell for the fourth month in five. The Singapore-traded SGX Nifty, an early barometer of India’s benchmark Nifty 50, fell 0.72% to 16,440 points as of 6:40 am. Oil rose above $115 a barrel ahead of a meeting of ministers from the group on Thursday to discuss its supply policy for July.

Economic Calendar:

• INR: Trade Balance on 2^nd June 2022.
• INR: Manufacturing PMI on 1^st  June 2022.
• USD: Mortgage Market Index 1^st June, 2022.
• USD: ADP Non Payroll Job Data 1^st June, 2022.

Brokerage Radar:

CLSA ON INFOSYS: (Analyst meet takeaways) Buy, TP Rs 2040 Message 1: no visible impact of potential macro headwinds Message 2: longer-term strategy of a sharper focus on digital/cloud continues Message 3: structural comfort on margin despite near-term pressure

CREDIT SUISSE ON AUROBINDO PHARMA: O-P, TP cut to Rs 790 from Rs 855 Good FCF generation in 4Q; upside catalyst is value unlocking in Injectables CUT FY24 EPS by 4% Call takeaways 1)Biosimilar:1 filing by 1QFY24 & 2 by 4QFY24 2) Phase III trial of Pneumococcal Conjugate Vaccine complete.

GOLDMAN SACHS ON AUROBINDO PHARMA: Buy, TP cut to Rs 720 4Q: Slow & steady recovery, val provide comfort Co refrained from any guidance given uncertain environment However, remains confident of scaling up its global injectable to its earlier guidance of $650-700m by FY24

CREDIT SUISSE ON USL: Neutral, TP cut to Rs 900 Sale of Popular brands a favourable move; Margin headwinds to persist in near term USL seeing double-digit inflation on overall RM basket With price hikes remaining a challenge, co would have to speed up productivity gains to support margins.

International Markets:

U.S & Europe:

Asian markets:

ADR Watch:

Commodities & Currency:

FIIs & DII:

News Update

Vodafone Idea: The company denied media reports that said it is in talks with Amazon and other investors to raise Rs 20,000 crore.

HFCL: The company has received order worth Rs 237.25 crore from a domestic private telecom operator for supply of optical fibre cables.

Rail Vikas Nigam: The Northeast Frontier Railway has awarned RVNL-Bhartia a contract for the construction of single-line BG tunnel at an estimated project cost of Rs 560 crore.

Bharat Dynamics: The company has signed a contract worth Rs 2,971 crore with the Ministry of Defence to supply ASTRA MK-I Beyond Visual Range Air to Air Missile and associated equipment to the Indian Air Force and Indian Na
Asian Granito: The income tax department carried out searches at various locations of the company from May 26-31.

Somany Ceramics: Chief Financial Officer Saikat Mukhopadhyay has resigned with effect from May 31.

Bata India: To sell 2.8% stake at floor price of Rs 1,750 (7% discount).

InterGlobe Aviation : IndiGo is talking to three-four more global carriers for operational alliances and could likely have 12 partnerships in the next two to three years, its chief executive reportedly said.

Gail India : As per reports, the company is looking to import one million metric tonnes of additional LNG for 10 years beginning 2023 to meet the country’s rising demand for fuel.

Venus Remedies : Promoter Pawan Chaudhary acquired 1.26 lakh equity shares in the company via open market transactions. His shareholding in the company has risen to 12.82 percent from 11.87 percent.

VIP Clothing : The company has approved an agreement for asset monetisation by way of sale of leasehold rights in respect of Umbergaon Plot.

Source: Moneycontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL